NPI: 1548224470 · NORFOLK, VA 23502 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/17/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/17/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 39,703 | $474K |
| 2019 | 37,451 | $465K |
| 2020 | 33,773 | $640K |
| 2021 | 28,851 | $669K |
| 2022 | 19,673 | $600K |
| 2023 | 13,136 | $326K |
| 2024 | 7,083 | $273K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 53,751 | 4,003 | $3.34M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 52,333 | 2,764 | $64K |
| J0606 | Injection, etelcalcetide, 0.1 mg | 1,594 | 118 | $15K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 440 | 243 | $12K |
| J1270 | Injection, doxercalciferol, 1 mcg | 30,469 | 2,432 | $9K |
| J1756 | Injection, iron sucrose, 1 mg | 12,127 | 2,400 | $3K |
| A4657 | Syringe, with or without needle, each | 12,222 | 3,418 | $3K |
| 90674 | 234 | 171 | $1K | |
| 83970 | 2,560 | 1,839 | $496.30 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 582 | 244 | $311.29 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 100 | 25 | $257.58 |
| G0008 | Administration of influenza virus vaccine | 255 | 192 | $105.31 |
| 82728 | 1,996 | 1,426 | $72.88 | |
| 83550 | 1,987 | 1,371 | $56.18 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 262 | 166 | $49.20 |
| 0012A | 42 | 27 | $47.12 | |
| 82108 | 520 | 404 | $44.24 | |
| 83540 | 2,055 | 1,420 | $41.58 | |
| 85041 | 3,060 | 2,168 | $38.74 | |
| 85048 | 3,015 | 2,140 | $33.10 | |
| 0011A | 40 | 29 | $20.00 | |
| 90661 | 13 | 13 | $1.59 | |
| 85045 | 13 | 12 | $0.26 |